DK144261B - - Google Patents
Download PDFInfo
- Publication number
- DK144261B DK144261B DK280174AA DK280174A DK144261B DK 144261 B DK144261 B DK 144261B DK 280174A A DK280174A A DK 280174AA DK 280174 A DK280174 A DK 280174A DK 144261 B DK144261 B DK 144261B
- Authority
- DK
- Denmark
- Prior art keywords
- allopurinol
- tablet
- weight
- tablet according
- tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2462873 | 1973-05-23 | ||
| GB2462873A GB1460302A (en) | 1973-05-23 | 1973-05-23 | Tablet formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK144261B true DK144261B (it) | 1982-02-01 |
| DK144261C DK144261C (da) | 1991-02-04 |
Family
ID=10214700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK280174AA DK144261C (da) | 1973-05-23 | 1974-05-22 | Medicinsk tablet indeholdende allopurinol |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS577128B2 (it) |
| AT (1) | AT351167B (it) |
| AU (1) | AU469472B2 (it) |
| BE (1) | BE815409A (it) |
| CA (1) | CA977279A (it) |
| CY (1) | CY941A (it) |
| DE (1) | DE2424950A1 (it) |
| DK (1) | DK144261C (it) |
| FI (1) | FI156674A (it) |
| FR (1) | FR2230341B1 (it) |
| GB (1) | GB1460302A (it) |
| HK (1) | HK1378A (it) |
| HU (1) | HU170656B (it) |
| IE (1) | IE39283B1 (it) |
| IL (1) | IL44877A (it) |
| IT (1) | IT8048966A0 (it) |
| KE (1) | KE2808A (it) |
| MY (1) | MY7800181A (it) |
| NL (1) | NL190436C (it) |
| SE (1) | SE402525C (it) |
| ZA (1) | ZA743318B (it) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1533243A (en) * | 1975-02-13 | 1978-11-22 | Wellcome Found | Tablet formulation |
| US4143129A (en) | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
| US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| DE3839825A1 (de) * | 1988-11-25 | 1990-06-13 | Henning Berlin Gmbh | Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze |
| WO1996002234A1 (es) * | 1994-07-18 | 1996-02-01 | Luis Cipriano Carvajal Martin | Granulos compactos altamente autodisgregantes para uso en formas galenicas conteniendo principios activos insolubles o poco solubles |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB975850A (en) * | 1955-08-10 | 1964-11-18 | Wellcome Found | Xanthine oxidase inhibitors |
| US3624205A (en) * | 1967-04-25 | 1971-11-30 | Burroughs Wellcome Co | Treatment of hyperuricemia in humans |
-
1973
- 1973-05-23 GB GB2462873A patent/GB1460302A/en not_active Expired
-
1974
- 1974-05-22 ZA ZA00743318A patent/ZA743318B/xx unknown
- 1974-05-22 DE DE19742424950 patent/DE2424950A1/de active Pending
- 1974-05-22 IE IE1097/74A patent/IE39283B1/xx unknown
- 1974-05-22 CA CA200,536A patent/CA977279A/en not_active Expired
- 1974-05-22 SE SE7406864A patent/SE402525C/sv not_active IP Right Cessation
- 1974-05-22 IL IL44877A patent/IL44877A/en unknown
- 1974-05-22 NL NLAANVRAGE7406873,A patent/NL190436C/xx not_active IP Right Cessation
- 1974-05-22 HU HUWE507A patent/HU170656B/hu unknown
- 1974-05-22 BE BE144636A patent/BE815409A/xx not_active IP Right Cessation
- 1974-05-22 JP JP5776774A patent/JPS577128B2/ja not_active Expired
- 1974-05-22 FI FI1566/74A patent/FI156674A/fi unknown
- 1974-05-22 AT AT426774A patent/AT351167B/de not_active IP Right Cessation
- 1974-05-22 DK DK280174AA patent/DK144261C/da not_active IP Right Cessation
- 1974-05-22 FR FR7417820A patent/FR2230341B1/fr not_active Expired
- 1974-05-22 AU AU69252/74A patent/AU469472B2/en not_active Expired
- 1974-05-23 CY CY941A patent/CY941A/xx unknown
- 1974-12-02 KE KE2808A patent/KE2808A/xx unknown
-
1978
- 1978-01-05 HK HK13/78A patent/HK1378A/xx unknown
- 1978-12-31 MY MY1978181A patent/MY7800181A/xx unknown
-
1980
- 1980-06-13 IT IT8048966A patent/IT8048966A0/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL44877A (en) | 1976-11-30 |
| FR2230341B1 (it) | 1977-04-15 |
| JPS577128B2 (it) | 1982-02-09 |
| FR2230341A1 (it) | 1974-12-20 |
| JPS5040721A (it) | 1975-04-14 |
| HK1378A (en) | 1978-01-13 |
| KE2808A (en) | 1978-02-17 |
| HU170656B (it) | 1977-07-28 |
| BE815409A (fr) | 1974-11-22 |
| IL44877A0 (en) | 1974-07-31 |
| ATA426774A (de) | 1978-12-15 |
| ZA743318B (en) | 1975-05-28 |
| IT8048966A0 (it) | 1980-06-13 |
| GB1460302A (en) | 1977-01-06 |
| DK144261C (da) | 1991-02-04 |
| CA977279A (en) | 1975-11-04 |
| IE39283L (en) | 1974-11-23 |
| AT351167B (de) | 1979-07-10 |
| NL190436B (nl) | 1993-10-01 |
| IE39283B1 (en) | 1978-09-13 |
| NL190436C (nl) | 1994-03-01 |
| NL7406873A (it) | 1974-11-26 |
| AU6925274A (en) | 1975-11-27 |
| CY941A (en) | 1978-06-23 |
| DE2424950A1 (de) | 1974-12-19 |
| SE402525B (sv) | 1978-07-10 |
| AU469472B2 (en) | 1976-02-12 |
| SE402525C (sv) | 1982-11-22 |
| MY7800181A (en) | 1978-12-31 |
| FI156674A (it) | 1974-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2474674C (en) | Solid preparation containing single crystal form | |
| NO174876B (no) | Fremgangsmåte for fremstilling av et medikament i form av granuler basert på fenofibrat, innbefattende en inert kjerne | |
| US4900558A (en) | Sustained release ibuprofen formulation including a core of ibuprofen and a microcrystalline cellulose and a covering of acrylic polymer and hydroxylated cellulose derivative | |
| SE453797B (sv) | Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt | |
| NO344367B1 (no) | Et fysisk og kjemisk stabilt nikotin-inneholdende partikkelformet materiale | |
| NO175884B (no) | Fremgangsmåte for fremstilling av en presset tablett som inneholder methylprednisolon og et super-desintegrasjonsmiddel | |
| JP2011144194A (ja) | 医薬組成物 | |
| CN104382868B (zh) | 口腔可分散的甘露醇 | |
| CZ20022429A3 (cs) | Glyburidová kompozice | |
| AU753482B2 (en) | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates | |
| JP4636796B2 (ja) | ルミラコキシブ含有医薬組成物 | |
| Alhalmi et al. | Sustained release matrix system: an overview | |
| NL8203343A (nl) | Farmaceutisch preparaat. | |
| CN108201529B (zh) | 一种含有尿酸转运蛋白抑制剂的药物组合物及其制备方法 | |
| DK144261B (it) | ||
| AU2002213900A1 (en) | Pharmaceutical compositions | |
| NO774400L (no) | Fremgangsmaate til fremstilling av farmasoeytiske sammensetninger | |
| DK143247B (da) | Medicinsk tablet indeholdende som aktiv bestanddel en 2,4-diamino-5-benzylpyrimidin sammen med et sulfonamid | |
| Panda et al. | Optimization of diclofenac sodium orodispersible tablets with natural disintegrants using response surface Methodology | |
| RU2145213C1 (ru) | Фармацевтическая композиция, обладающая ноотропным действием, и способ ее получения | |
| SE452550B (sv) | Tablett med fordrojd frigoring av teofyllin | |
| Bhattacharya et al. | Orodispersible Tablet in Treatment of Migraine: Opportunities, Challenges and Recent Advancements | |
| Pandurangan et al. | Fast dissolving tablets-An overview | |
| CN115463101B (zh) | 一种稳定的多替拉韦钠片及其制备方法 | |
| US3642993A (en) | Pharmaceutical composition containing 2-methyl - 5 - phenyl - 1 2-dihydro-3h-2-benzazepine for treatment of a condition associated with anxiety or tension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |